Form 8-K - Current report:
SEC Accession No. 0001104659-24-000868
Filing Date
2024-01-03
Accepted
2024-01-03 16:30:44
Documents
12
Period of Report
2023-12-29
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm241751d1_8k.htm   iXBRL 8-K 28616
  Complete submission text file 0001104659-24-000868.txt   200412

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA nviv-20231229.xsd EX-101.SCH 3045
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE nviv-20231229_lab.xml EX-101.LAB 34240
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nviv-20231229_pre.xml EX-101.PRE 22379
6 EXTRACTED XBRL INSTANCE DOCUMENT tm241751d1_8k_htm.xml XML 3227
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37350 | Film No.: 24507045
SIC: 3841 Surgical & Medical Instruments & Apparatus
(CF Office: 08 Industrial Applications and Services)